Melanie Schultz

This inventor holds 18 USPTO granted patents and 3 published patent applications, plus 12 CIPO patents and 19 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Merck Patent Gmbh, Merck Patent Gesellschaft. Active years: 2009-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Melanie Schultz. Retrieved from https://idiyas.com/inventor/melanie-schultz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 18 (Patent Applications = 3)

% Patents Active = 11.1

CIPO Patents = 12

EPO Patents = 19 (Patent Applications = 19)

Average Co-Inventor Count = 3.8

ph-index = 8

Forward Citations = 205(Granted Patents)

Company Filing History:

Merck Patent Gesellschaft

patents

Years Active: 2009-2016

Loading Chart...

Areas of Expertise:

Piperidine Derivatives

Autotaxin Inhibitors

Piperazine Derivatives

Heterocyclic Compounds

Triazolopyrazine

Thiazole Derivatives

Cancer Treatment

Lysophosphatidic Acid Antagonists

Benzonaphthyridinamines

Sulfoxide Derivatives

11-Beta-Hydroxysteroid Dehydrogenase

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9452997 - Piperidine and piperazine derivatives as autotaxin inhibitors (2016-09-27),

2. 9029387 - Benzonaphthyridinamines as autotaxin inhibitors (2015-05-12),

3. 9023851 - Triazolopyrazine derivatives (2015-05-05),

4. 9006440 - Furopyridine derivatives (2015-04-14),

5. 8912202 - N-(benzimimdazol-2-yl)-cyclopropane carboxamides as lysophosphatidic acid antagonists (2014-12-16),

6. 8841324 - Heterocyclic compounds as autotaxin inhibitors (2014-09-23),

7. 8822476 - Piperidine and piperazine derivatives as autotaxin inhibitors (2014-09-02),

8. 8791111 - Piperidine and piperazine derivatives (2014-07-29),

9. 8754097 - Piperidine and piperazine derivatives (2014-06-17),

10. 8557824 - Thiazole derivatives (2013-10-15),

11. 8552001 - Sulfoxide derivatives for the treatment of tumors (2013-10-08),

12. 8530650 - 2, 5-diamino-substituted pyrido [4, 3-D] pyrimidines as autotaxin inhibitors against cancer (2013-09-10),

13. 8497283 - Autotaxin inhibitors (2013-07-30),

14. 8470849 - 7-azaindole derivatives as selective 11-β-hydroxysteroid dehydrogenase type 1 inhibitors (2013-06-25),

15. 8329907 - Autotaxin inhibitors (2012-12-11),

Title: The Innovative Contributions of Melanie Schultz

Introduction

Melanie Schultz is a prominent inventor based in Darmstadt, Germany. She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target autotaxin, an enzyme implicated in various diseases.

Latest Patents

Melanie Schultz holds 18 patents to her name. Her latest patents include "Piperidine and piperazine derivatives as autotaxin inhibitors," which describes the use of these compounds for treating conditions associated with increased lysophosphatidic acid levels, particularly different types of cancer. Another notable patent is "Benzonaphthyridinamines as autotaxin inhibitors," which focuses on the use of these compounds in the treatment of various cancers and autoimmune diseases.

Career Highlights

Throughout her career, Melanie has worked with notable companies such as Merck Patent GmbH and Merck Patent Gesellschaft. Her work has been instrumental in advancing the understanding and treatment of diseases linked to autotaxin.

Collaborations

Melanie has collaborated with esteemed colleagues, including Kai Schiemann and Wolfgang Staehle, contributing to a rich exchange of ideas and innovations in her field.

Conclusion

Melanie Schultz's innovative work in developing autotaxin inhibitors showcases her dedication to advancing medical science. Her contributions continue to impact the treatment of serious health conditions, highlighting her role as a leading inventor in the field.

Profile summary based on public USPTO records.